BCD-033

interferon beta-1a biosimilar · Biocad

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BCD-033, covering 2015-02-16 to 2023-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple Sclerosis [Phase 2, Phase 3]

See pricing